Major factors affecting the Company's operating results include net revenues of its bioequivalent versions of Cardizem CD, and, to a lesser extent, its line of OTC Claritin products, Glucophage, Glucotrol XL, Tiazac, net sales of its Altocor brand product, the launches of Fortamet and Cardura XL
and KUDCo licensing revenue.
diuretic (thiazide) and Cardura XL
(doxazosin GITS), if needed.
Filed in April 2001, the Company anticipates FDA approval of Cardura XL in mid-2004.
We are eager to begin marketing the benefits of Cardura XL to both general practitioners and urologists, who can then make this important medicine available to their patients.
In connection with the addition of Cardura XL, Andrx is in the process of determining how to adjust the utilization and size of its brand sales force to more appropriately handle the brand products it intends to promote in 2004.